MicroStrategy
MSTR
Tesla
TSLA
MARA Holdings
MARA
Coinbase
COIN
Amazon
AMZN
US Stock MarketDetailed Quotes
ACET Adicet Bio
- 0.916
- +0.023+2.52%
Close Dec 24 13:00 ET
- 0.916
- +0.000+0.01%
Pre 08:07 ET
75.50MMarket Cap-0.54P/E (TTM)
0.930High0.851Low544.02KVolume0.893Open0.894Pre Close490.61KTurnover0.88%Turnover RatioLossP/E (Static)82.40MShares3.77052wk High0.36P/B56.89MFloat Cap0.81052wk Low--Dividend TTM62.10MShs Float214.348Historical High--Div YieldTTM8.82%Amplitude0.810Historical Low0.901Avg Price1Lot Size
Adicet Bio Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -3.62%-22.01M | 5.93%-23.42M | 5.17%-22.85M | -109.35%-93.72M | -24.68%-23.49M | -38.56%-21.24M | -69.32%-24.9M | -686.94%-24.09M | 12.31%-44.77M | -40.11%-18.84M |
| Net income from continuing operations | 38.90%-30.48M | 7.72%-29.9M | 9.28%-28.02M | -104.41%-142.66M | 1.29%-29.49M | -126.80%-49.89M | -43.77%-32.4M | -768.71%-30.88M | -12.57%-69.79M | -88.93%-29.88M |
| Operating gains losses | ---- | ---- | ---- | -107.41%-4K | ---- | ---- | ---- | ---- | 74.19%54K | --0 |
| Depreciation and amortization | -3.22%1.59M | 6.09%1.6M | 31.66%1.65M | 136.82%6.1M | 59.49%1.69M | 116.73%1.65M | 272.84%1.51M | 256.25%1.25M | 67.43%2.58M | 190.14%1.06M |
| Other non cash items | 7.48%805K | 1.02%793K | 41.18%816K | 13.78%2.87M | -4.27%762K | 83.58%749K | 19.12%785K | -12.82%578K | 46.52%2.53M | 126.14%796K |
| Change In working capital | -134.12%-420K | -1,132.26%-1.92M | -1,667.89%-2.98M | -90.82%252K | -127.47%-1.36M | -3.30%1.23M | -92.36%186K | 103.22%190K | 145.30%2.74M | 299.80%4.93M |
| -Change in prepaid assets | -94.21%33K | -5,339.29%-1.52M | -193.46%-200K | -31.05%926K | 148.16%170K | 37.02%570K | -113.79%-28K | -80.13%214K | -17.81%1.34M | -116.84%-353K |
| -Change in payables and accrued expense | -72.21%394K | -58.14%409K | 23.20%-1.98M | -112.37%-933K | -112.15%-746K | 37.67%1.42M | -60.62%977K | -22.43%-2.58M | 280.28%7.54M | 19,084.38%6.14M |
| -Change in other current assets | -1.14%87K | 5.38%98K | 9.52%92K | -61.46%358K | 2,425.00%93K | -83.24%88K | -68.04%93K | -28.21%84K | 2,111.90%929K | -103.25%-4K |
| -Change in other current liabilities | -10.53%-934K | -5.61%-904K | -135.89%-888K | 95.63%-99K | -25.83%-872K | -26.31%-845K | -58.23%-856K | 785.32%2.47M | -343.05%-2.26M | -216.86%-693K |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 47.63%-4.81M | --0 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -3.62%-22.01M | 5.93%-23.42M | 5.17%-22.85M | -109.35%-93.72M | -24.68%-23.49M | -38.56%-21.24M | -69.32%-24.9M | -686.94%-24.09M | 12.31%-44.77M | -40.11%-18.84M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -10,560.15%-96.58M | 79.96%-302K | 87.52%-239K | 73.40%-4.46M | 97.90%-136K | 81.17%-906K | 47.10%-1.51M | 27.24%-1.92M | -500.21%-16.78M | -110.85%-6.49M |
| Net PPE purchase and sale | 55.74%-401K | 79.96%-302K | 87.52%-239K | 73.40%-4.46M | 97.90%-136K | 81.17%-906K | 47.10%-1.51M | 27.24%-1.92M | -28.64%-16.78M | -110.85%-6.49M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -10,560.15%-96.58M | 79.96%-302K | 87.52%-239K | 73.40%-4.46M | 97.90%-136K | 81.17%-906K | 47.10%-1.51M | 27.24%-1.92M | -500.21%-16.78M | -110.85%-6.49M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | -9.73%204K | 1,585,328.57%110.97M | -99.43%236K | -75.00%76K | -100.14%-59K | 38.65%226K | 99.38%-7K | -82.90%41.51M | -99.69%304K |
| Net common stock issuance | --0 | --0 | --110.92M | --0 | --0 | --0 | --0 | --0 | -81.79%43.36M | --0 |
| Proceeds from stock option exercised by employees | --0 | -9.73%204K | 6,200.00%189K | -77.90%386K | -85.41%157K | --0 | -41.45%226K | -96.81%3K | -63.73%1.75M | -66.32%1.08M |
| Net other financing activities | --0 | --0 | -1,310.00%-141K | 95.83%-150K | 89.51%-81K | 95.71%-59K | --0 | 99.19%-10K | -1,278.54%-3.6M | -621.50%-772K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | -9.73%204K | 1,585,328.57%110.97M | -99.43%236K | -75.00%76K | -100.14%-59K | 38.65%226K | 99.38%-7K | -82.90%41.51M | -99.69%304K |
| Net cash flow | ||||||||||
| Beginning cash position | 9.06%224.07M | 6.89%247.59M | -38.01%159.71M | -7.22%257.66M | -35.17%183.26M | -21.17%205.46M | -16.69%231.64M | -7.22%257.66M | 212.52%277.69M | 43.67%282.68M |
| Current changes in cash | -434.10%-118.59M | 10.16%-23.52M | 437.78%87.88M | -388.80%-97.95M | 5.90%-23.55M | -200.75%-22.2M | -50.54%-26.18M | -7,774.34%-26.02M | -110.61%-20.04M | -130.92%-25.02M |
| End cash Position | -42.44%105.48M | 9.06%224.07M | 6.89%247.59M | -38.01%159.71M | -38.01%159.71M | -35.17%183.26M | -21.17%205.46M | -16.69%231.64M | -7.22%257.66M | -7.22%257.66M |
| Free cash flow | -1.19%-22.41M | 10.16%-23.72M | 11.23%-23.09M | -59.52%-98.18M | 6.73%-23.62M | -9.96%-22.14M | -50.43%-26.41M | -1,865.72%-26.01M | 3.98%-61.55M | -53.29%-25.33M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.